United Imaging Healthcare reports 19.4% revenue growth for first nine months of 2026

United Imaging Healthcare (688271.SH) generated 10.58 billion yuan in revenue during the first nine months of 2026, marking a 19.43% increase compared to the same period last year. International revenue played a significant role in this performance, recording a growth rate of 50.30%.

The Shanghai-based medical imaging equipment manufacturer continues to expand its footprint in international markets, shifting its reliance away from purely domestic growth. This financial performance reflects the firm's ongoing efforts to compete with established global players in the diagnostic imaging sector.

The reported figures underscore a period of scaling for the company, as it attempts to integrate its advanced imaging solutions into broader hospital networks globally. Market analysts will continue to monitor whether this pace of international expansion can be sustained amidst global supply chain challenges.